Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Times cited: 71
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.
Radiotherapy and Oncology.
Times cited: 173
Postoperative radiotherapy for oral cavity cancers: Impact of anatomic subsite on treatment outcome.
Head and Neck.
Times cited: 63